Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Richard VR"'
Proteomic evidence of depression-associated astrocytic dysfunction in the human male olfactory bulb.
Autor:
Rahimian R; McGill Group for Suicide Studies, Douglas Mental Health University Institute, Verdun, QC, Canada; Department of Psychiatry, McGill University, Montreal, QC, Canada., Perlman K; McGill Group for Suicide Studies, Douglas Mental Health University Institute, Verdun, QC, Canada; Integrated Program in Neuroscience, McGill University, Montreal, QC, Canada., Fakhfouri G; Department of Psychiatry, Douglas Hospital, McGill University, Montreal, QC, Canada., Mpai R; McGill Group for Suicide Studies, Douglas Mental Health University Institute, Verdun, QC, Canada; Integrated Program in Neuroscience, McGill University, Montreal, QC, Canada., Richard VR; Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montréal, QC, Canada., Hercher C; McGill Group for Suicide Studies, Douglas Mental Health University Institute, Verdun, QC, Canada; Integrated Program in Neuroscience, McGill University, Montreal, QC, Canada., Penney L; Department of Psychiatry, Douglas Hospital, McGill University, Montreal, QC, Canada., Davoli MA; McGill Group for Suicide Studies, Douglas Mental Health University Institute, Verdun, QC, Canada; Department of Psychiatry, McGill University, Montreal, QC, Canada., Nagy C; McGill Group for Suicide Studies, Douglas Mental Health University Institute, Verdun, QC, Canada; Department of Psychiatry, McGill University, Montreal, QC, Canada; Integrated Program in Neuroscience, McGill University, Montreal, QC, Canada., Zahedi RP; Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada; Manitoba Centre for Proteomics and Systems Biology, University of Manitoba, Winnipeg, MB, Canada; Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, MB, Canada; CancerCare Manitoba Research Institute, Winnipeg, MB, Canada., Borchers CH; Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montréal, QC, Canada; Gerald Bronfman Department of Oncology, McGill University, Montréal, Québec, Canada; Department of Pathology, McGill University, Montréal, QC, Canada; Department of Experimental Medicine, McGill University, Montreal, QC, Canada., Giros B; Department of Psychiatry, Douglas Hospital, McGill University, Montreal, QC, Canada., Turecki G; McGill Group for Suicide Studies, Douglas Mental Health University Institute, Verdun, QC, Canada; Department of Psychiatry, McGill University, Montreal, QC, Canada; Integrated Program in Neuroscience, McGill University, Montreal, QC, Canada., Mechawar N; McGill Group for Suicide Studies, Douglas Mental Health University Institute, Verdun, QC, Canada; Department of Psychiatry, McGill University, Montreal, QC, Canada; Integrated Program in Neuroscience, McGill University, Montreal, QC, Canada. Electronic address: naguib.mechawar@mcgill.ca.
Publikováno v:
Brain, behavior, and immunity [Brain Behav Immun] 2024 Aug 14; Vol. 122, pp. 110-121. Date of Electronic Publication: 2024 Aug 14.
Autor:
Carvalho Cabral P; Douglas Research Centre, McGill University, Montreal, Quebec, Canada., Richard VR; Lady Davis Institute for Medical Research, McGill University, Montreal, Quebec, Canada., Borchers CH; Lady Davis Institute for Medical Research, McGill University, Montreal, Quebec, Canada., Olivier M; Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada., Cermakian N; Douglas Research Centre, McGill University, Montreal, Quebec, Canada.
Publikováno v:
ImmunoHorizons [Immunohorizons] 2024 Jun 01; Vol. 8 (6), pp. 442-456.
Autor:
Richard VR; Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Quebec H3T 1E2, Canada., Mitsa G; Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Quebec H3T 1E2, Canada.; Division of Experimental Medicine, McGill University, Montréal, Quebec H4A 3J1, Canada., Eshghi A; University of Victoria-Genome BC Proteomics Centre, Victoria, British Columbia V8Z 7X8, Canada., Chaplygina D; Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Quebec H3T 1E2, Canada., Mohammed Y; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden 2333 ZC, The Netherlands., Goodlett DR; University of Victoria-Genome BC Proteomics Centre, Victoria, British Columbia V8Z 7X8, Canada., Zahedi RP; Manitoba Centre for Proteomics and Systems Biology, Winnipeg, Manitoba R3E 3P4, Canada.; Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba R3E 3P4, Canada.; Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba R3E 0J9, Canada.; CancerCare Manitoba Research Institute, Winnipeg, Manitoba R3E 0V9, Canada., Thevis M; Institute of Biochemistry, Center for Preventive Doping Research, German Sport University Cologne, Cologne 50933, Germany.; European Monitoring Center for Emerging Doping Agents (EuMoCEDA), Cologne/Bonn 50933, Germany., Borchers CH; Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Quebec H3T 1E2, Canada.; Division of Experimental Medicine, McGill University, Montréal, Quebec H4A 3J1, Canada.; Gerald Bronfman Department of Oncology, McGill University, Montréal, Quebec H4A 3T2, Canada.; Department of Pathology, McGill University, Montréal, Quebec H4A 3J1, Canada.
Publikováno v:
Journal of proteome research [J Proteome Res] 2024 May 03; Vol. 23 (5), pp. 1779-1787. Date of Electronic Publication: 2024 Apr 24.
Autor:
Sobsey CA; Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, QC, Canada.; Division of Experimental Medicine, Faculty of Medicine, McGill University, Montreal, QC, Canada., Mady N; Division of Experimental Medicine, Faculty of Medicine, McGill University, Montreal, QC, Canada.; Peter Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, QC, Canada., Richard VR; Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, QC, Canada., LeBlanc A; Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, QC, Canada., Zakharov T; Division of Experimental Medicine, Faculty of Medicine, McGill University, Montreal, QC, Canada.; Peter Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, QC, Canada., Borchers CH; Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, QC, Canada.; Gerald Bronfman Department of Oncology, Jewish General Hospital, McGill University, Montreal, QC, Canada., Jagoe RT; Peter Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, QC, Canada.; Department of Medicine, Jewish General Hospital, Montreal, QC, Canada.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2024 Feb 02; Vol. 15, pp. 1232595. Date of Electronic Publication: 2024 Feb 02 (Print Publication: 2024).
Autor:
Zhang AMY; Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada., Xia YH; Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada., Lin JSH; Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada., Chu KH; Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada., Wang WCK; Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada., Ruiter TJJ; Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada., Yang JCC; Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada., Chen N; Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada., Chhuor J; Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada., Patil S; Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada., Cen HH; Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada., Rideout EJ; Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada., Richard VR; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada., Schaeffer DF; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z7, Canada., Zahedi RP; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada; Department of Internal Medicine, University of Manitoba, Winnipeg, MB R3A 1R9, Canada; Manitoba Centre for Proteomics and Systems Biology, Winnipeg, MB R3E 3P4, Canada., Borchers CH; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada; Gerald Bronfman Department of Oncology, Jewish General Hospital, McGill University, Montreal, QC H4A 3T2, Canada., Johnson JD; Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada. Electronic address: james.d.johnson@ubc.ca., Kopp JL; Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada. Electronic address: janel.kopp@ubc.ca.
Publikováno v:
Cell metabolism [Cell Metab] 2023 Dec 05; Vol. 35 (12), pp. 2119-2135.e5. Date of Electronic Publication: 2023 Oct 31.
Autor:
Castillo-Castrejon M; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA., Sankofi BM; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA., Murguia SJ; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA., Udeme AA; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA., Cen HH; Life Sciences Institute, University of British Columbia, Vancouver, Canada., Xia YH; Life Sciences Institute, University of British Columbia, Vancouver, Canada., Thomas NS; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA., Berry WL; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA., Jones KL; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA., Richard VR; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital and McGill University, Montreal, QC, Canada., Zahedi RP; Manitoba Centre for Proteomics and Systems Biology, Winnipeg, MB, R3E 3P4, Canada.; Department of Internal Medicine, University of Manitoba, Winnipeg, MB, R3E 3P4, Canada.; Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, MB, R3E 0J9, Canada.; CancerCare Manitoba Research Institute, Winnipeg, MB, R3E 0V9, Canada., Borchers CH; Manitoba Centre for Proteomics and Systems Biology, Winnipeg, MB, R3E 3P4, Canada.; Gerald Bronfman Department of Oncology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, H3T 1E2, Canada.; Division of Experimental Medicine, McGill University, Montreal, QC, H4A 3J1, Canada.; Department of Pathology, McGill University, Montreal, QC, H3A 2B4, Canada., Johnson JD; Life Sciences Institute, University of British Columbia, Vancouver, Canada., Wellberg EA; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA. elizabeth-wellberg@ouhsc.edu.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2023 Aug 22; Vol. 25 (1), pp. 99. Date of Electronic Publication: 2023 Aug 22.
Autor:
Mitsa G; Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.; Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research and Jewish General Hospital, and McGill University, Montréal, Québec, Canada.; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada., Richard VR; Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research and Jewish General Hospital, and McGill University, Montréal, Québec, Canada.; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada., Majedi Y; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada., Lafleur J; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada., Aguilar-Mahecha A; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada., Basik M; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.; Department of Surgery, Jewish General Hospital, Montréal, Québec, Canada.; Gerald Bronfman Department of Oncology, McGill University, Montréal, Québec, Canada., Borchers CH; Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.; Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research and Jewish General Hospital, and McGill University, Montréal, Québec, Canada.; Gerald Bronfman Department of Oncology, McGill University, Montréal, Québec, Canada.; Department of Pathology, McGill University, Montréal, Québec, Canada.
Publikováno v:
Expert review of proteomics [Expert Rev Proteomics] 2023 Apr-Jun; Vol. 20 (4-6), pp. 87-92. Date of Electronic Publication: 2023 Jun 13.
Autor:
Prabhu SA; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.; Division of Experimental Medicine, McGill University, Montréal, Québec, Canada., Moussa O; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.; Division of Experimental Medicine, McGill University, Montréal, Québec, Canada., Gonçalves C; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada., LaPierre JH; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.; Division of Experimental Medicine, McGill University, Montréal, Québec, Canada., Chou H; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada., Huang F; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.; Division of Experimental Medicine, McGill University, Montréal, Québec, Canada., Richard VR; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada., Ferruzo PYM; Centre de recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada.; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Québec, Canada., Guettler EM; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada., Soria-Bretones I; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Kirby L; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Gagnon N; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada., Su J; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada., Silvester J; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Krisna SS; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada., Rose AAN; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.; Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.; Gerald Bronfman Department of Oncology, McGill University, Montréal, Québec, Canada., Sheppard KE; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia., Cescon DW; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; University of Toronto, Toronto, Ontario, Canada., Mallette FA; Centre de recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada.; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Québec, Canada.; Department of Medicine, Université de Montréal, Montréal, Québec, Canada., Zahedi RP; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.; McGill Centre for Translational Research in Cancer, McGill University, Montréal, Québec, Canada., Borchers CH; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.; Gerald Bronfman Department of Oncology, McGill University, Montréal, Québec, Canada.; McGill Centre for Translational Research in Cancer, McGill University, Montréal, Québec, Canada., Del Rincon SV; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.; Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.; McGill Centre for Translational Research in Cancer, McGill University, Montréal, Québec, Canada., Miller WH; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.; Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.; McGill Centre for Translational Research in Cancer, McGill University, Montréal, Québec, Canada.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2023 Feb 01; Vol. 22 (2), pp. 192-204.
Autor:
Gaither C; MRM Proteomics Inc, Montreal, QC, Canada., Popp R; MRM Proteomics Inc, Montreal, QC, Canada., Richard VR; Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, QC, Canada., Zahedi RP; Manitoba Centre for Proteomics and Systems Biology, Winnipeg, MB, Canada.; Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada.; Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, MB, Canada., Borchers CH; Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, QC, Canada. christoph.borchers@mcgill.ca.; Division of Experimental Medicine, McGill University, Montreal, QC, Canada. christoph.borchers@mcgill.ca.; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, Canada. christoph.borchers@mcgill.ca.; Department of Pathology, McGill University, Montreal, QC, Canada. christoph.borchers@mcgill.ca.; Segal Cancer Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada. christoph.borchers@mcgill.ca.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2023; Vol. 2628, pp. 353-364.
Autor:
Preston SEJ; Division of Experimental Medicine, McGill University, Montreal, QC, Canada.; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, Canada.; Segal Cancer Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada., Richard VR; Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.; Segal Cancer Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada., Del Rincón SV; Division of Experimental Medicine, McGill University, Montreal, QC, Canada.; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, Canada.; Segal Cancer Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada., Borchers CH; Division of Experimental Medicine, McGill University, Montreal, QC, Canada. christoph.borchers@mcgill.ca.; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, Canada. christoph.borchers@mcgill.ca.; Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada. christoph.borchers@mcgill.ca.; Department of Pathology, Jewish General Hospital, McGill University, Montreal, Canada. christoph.borchers@mcgill.ca.; Segal Cancer Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada. christoph.borchers@mcgill.ca., Zahedi RP; Manitoba Centre for Proteomics and Systems Biology, Winnipeg, MB, Canada. rene.zahedi@umanitoba.ca.; Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada. rene.zahedi@umanitoba.ca.; Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, MB, Canada. rene.zahedi@umanitoba.ca.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2023; Vol. 2614, pp. 261-271.